Concepedia
Cell Proliferation · 2019 · 21 citations · 51 references
Open access
Our study not only emphasizes the regulatory mechanism of SETD2 in CML, but also provides promising therapeutic strategies for overcoming the imatinib resistance in patients with CML.
51
DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development
Masaki Okano, Daphne W. Bell, Daniel A. Haber et al. · Cell · 1999 · 6K citations · Full text
Histone Modifications, Chromatin, Dna Methyltransferases Dnmt3a +13
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Brian Druker, Moshe Talpaz, Debra Resta et al. · New England Journal of Medicine · 2001 · 5.2K citations · Full text
A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
Janet D. Rowley · Nature · 1973 · 4.3K citations
Hematological Malignancy, Chromatin, Cytogenetics +12
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
En Li, Timothy H. Bestor, Rudolf Jaenisch · Cell · 1992 · 3.9K citations
Developmental Biology, Embryonic Lethality, Epigenetic Change +8
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Stephen G. O’Brien, François Guilhot, Richard A. Larson et al. · New England Journal of Medicine · 2003 · 3.5K citations · Full text